EVERSANA’s Post

❓ How do you develop connected therapeutics that improve patient outcomes while safeguarding #sustainability? SHL Medical solves such a complex problem with a simple solution: Molly® Connected Cap. During a presentation in Japan, SHL’s Nagisa Kobashi highlighted the sustainability aspect of our Molly Connected Cap – a compact, retrofittable autoinjector cap add-on that records and transmits data on patients’ use of the product. The device is designed with a focus on process optimization as it leverages the modularity of Molly’s infrastructure. Beyond that, the Connected Cap’s pre-injection removal ensures the separation of the module from any contaminated part. Watch the clip 🎬 to understand what other benefits Molly Connected Cap can bring for pharma and biotech companies. #DrugDelivery #ThoughtLeader #DigitalHealth

Intrigued by the synergistic potential of biotech startups and Big Pharma, I reflect on how their collaboration is more than necessary; it's a transformative force in healthcare. Our latest Ambrosia Ventures LLC blog delves into this intricate dance of innovation. #BiotechPharmaCollaboration is not just a buzzword – it's a roadmap to pioneering medical advancements.

Come learn "The Art of Creating Practical Win-Win-Win Innovation for Patients, Providers, and Pharma" with three outstanding experts: Nandini Nayar, José Ma. Guido Avila, and Xander Kerman Gregory at the DHC Summit on June 25th. These three thoughtful leaders will share complimentary perspectives on leveraging emerging technology to change patients' lives, balanced with the real challenges of doing so in a regulated environment. It has never been more important for pharma to find practical innovations that drive business impact quickly. Join us at Amgen (Deerfield, IL) to discuss how to find the right opportunities to build positive-sum tools that work at scale. https://lnkd.in/evSXaYdx

We're excited to share our latest blog on the 'Clash or Collaborate' conundrum facing the life sciences industry. Discover how biotech startups and Big Pharma can leverage their unique strengths through collaboration to revolutionize healthcare. Dive into our exploration of this symbiotic relationship that could dictate the future of medical innovation. #BiotechPharmaCollaboration #LifeSciences #HealthcareInnovation Read more: https://lnkd.in/guWfvynY

The secret sauce to high precision manufacturing starts with a digital transformation journey that walks a mile in everyone's shoes in order to unlock the obvious and hidden data that resides across the factory in order deliver impactful data driven business decisions. Make this your year!! PM me for more details to learn more about the SmartFactory Rx solution suite and our team.

We ask our People to use the data and tools we decide to give them, we ask our People to input data throughout their workday to make the organization's data accurate...but we don't ask those same People what is the information they really need? What is efficient in helping them input their data to help the organization realize value from its Data Investments? In 2024 let's focus on the making data work to help our People do their job, hinder it. Understand their needs first before pushing the next digital solution. Mangers and Executives don't run companies - talented Leaders and People do. AI/ML won't save or fix it - the People are the greatest input and enablers of quality data your organization needs. #talentmanagement #aiml #datatransformation #workforcestrategy

Aris Gennadios discusses how Catalent is redefining drug delivery for a better patient experience with \#Zydis ODT and highlights how our partnership with ALK exemplifies the transformative potential of strategic innovation with a steadfast focus on meeting patient needs. Read the full article from The CEO Magazine here: https://ow.ly/Zm8s50ToE8y https://bit.ly/3N2izBO

Empowering Innovation in LCM: Re-Examining the Ideation Approach Innovation fuels success, even in the context of lifecycle management (LCM) in pharma. From redefining processes to removing internal barriers to creativity, learn how embracing creativity can transform your LCM strategy. Read More: https://lnkd.in/eaaiJEfR  #lifecyclemanagement #research#pharmaindustry #innovation  #lcmprocesses #lcmplanning

Aris Gennadios discusses how Catalent is redefining drug delivery for a better patient experience with \#Zydis ODT and highlights how our partnership with ALK exemplifies the transformative potential of strategic innovation with a steadfast focus on meeting patient need. Read the full article from The CEO Magazine here: https://ow.ly/Zm8s50ToE8y https://bit.ly/4gmkE93

Aris Gennadios discusses how Catalent is redefining drug delivery for a better patient experience with \#Zydis ODT and highlights how our partnership with ALK exemplifies the transformative potential of strategic innovation with a steadfast focus on meeting patient needs. Read the full article from The CEO Magazine here: https://ow.ly/Zm8s50ToE8y https://bit.ly/3ZGdcQ8